|
|
Volumn 20, Issue SPEC. ISS. JULY, 2008, Pages 21-55
|
|
Epidemiology and hemorrhagic risk factors of antivitamin K treatments;Épidémiologie et facteurs de isque hémorragique des traitements par les antivitamines K
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACENOCOUMAROL;
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
ANTIVITAMIN K;
COUMARIN;
DIPYRIDAMOLE;
HEPARIN;
PHENINDIONE;
PHENPROCOUMON;
PLACEBO;
WARFARIN;
XIMELAGATRAN;
ANTICOAGULANT THERAPY;
BLEEDING;
BRAIN HEMORRHAGE;
BRAIN ISCHEMIA;
CARDIOVASCULAR DISEASE;
CYP2C9 GENE;
DEEP VEIN THROMBOSIS;
DRUG DOSE COMPARISON;
DRUG OVERDOSE;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
EMBRYOPATHY;
FRANCE;
GENE;
GENETIC VARIABILITY;
HEART ATRIUM FIBRILLATION;
HEART INFARCTION;
HEART VALVE REPLACEMENT;
HUMAN;
INCIDENCE;
INTERNATIONAL NORMALIZED RATIO;
LUNG EMBOLISM;
MORBIDITY;
MORTALITY;
REVIEW;
RISK FACTOR;
STROKE;
THROMBOEMBOLISM;
THROMBOSIS;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT DURATION;
TREATMENT INDICATION;
TREATMENT OUTCOME;
|
|
EID: 50649099464
PISSN: 09997385
EISSN: None
Source Type: Journal
DOI: 10.1684/stv.2008.0308 Document Type: Review |
|
Times cited : (5)
|
|
References (0)
|
